866-997-4948(US-Canada Toll Free)

United States Gastrointestinal Therapeutics Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 118 Pages

Notes:
Sales, means the sales volume of Gastrointestinal Therapeutics
Revenue, means the sales value of Gastrointestinal Therapeutics

This report studies sales (consumption) of Gastrointestinal Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Shire Pharmaceuticals
GlaxoSmithKline
RedHill Biopharma
Salix Pharmaceuticals
TSD Japan
Ono Pharmaceutical
Zeria Pharmaceutical
Kissei Pharmaceutical
Kang Stem Biotech
Kaken Pharmaceutical
Hutchison Medi Pharma
Amgen

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Gastrointestinal Therapeutics in each application, can be divided into
IBD
Irritable Bowel Syndrome (IBS)

Table of Contents

United States Gastrointestinal Therapeutics Market Report 2017
1 Gastrointestinal Therapeutics Overview
1.1 Product Overview and Scope of Gastrointestinal Therapeutics
1.2 Classification of Gastrointestinal Therapeutics
1.2.1 Type I
1.2.2 Type II
1.3 Application of Gastrointestinal Therapeutics
1.3.1 IBD
1.3.2 Irritable Bowel Syndrome (IBS)
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Gastrointestinal Therapeutics (2012-2022)
1.4.1 United States Gastrointestinal Therapeutics Sales and Growth Rate (2012-2022)
1.4.2 United States Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Gastrointestinal Therapeutics Competition by Manufacturers
2.1 United States Gastrointestinal Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gastrointestinal Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gastrointestinal Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Gastrointestinal Therapeutics Market Competitive Situation and Trends
2.4.1 Gastrointestinal Therapeutics Market Concentration Rate
2.4.2 Gastrointestinal Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Gastrointestinal Therapeutics Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Gastrointestinal Therapeutics Sales and Market Share by States (2012-2017)
3.2 United States Gastrointestinal Therapeutics Revenue and Market Share by States (2012-2017)
3.3 United States Gastrointestinal Therapeutics Price by States (2012-2017)

4 United States Gastrointestinal Therapeutics Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Gastrointestinal Therapeutics Sales and Market Share by Type (2012-2017)
4.2 United States Gastrointestinal Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Gastrointestinal Therapeutics Price by Type (2012-2017)
4.4 United States Gastrointestinal Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Gastrointestinal Therapeutics Sales (Volume) by Application (2012-2017)
5.1 United States Gastrointestinal Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Gastrointestinal Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Gastrointestinal Therapeutics Manufacturers Profiles/Analysis
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Allergan
6.2.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Takeda
6.4.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Takeda Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Pfizer
6.6.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 F. Hoffmann-La Roche
6.8.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly
6.9.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 AstraZeneca
6.10.2 Gastrointestinal Therapeutics Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 AstraZeneca Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Procter & Gamble
6.12 Tillotts Pharma
6.13 Shire Pharmaceuticals
6.14 GlaxoSmithKline
6.15 RedHill Biopharma
6.16 Salix Pharmaceuticals
6.17 TSD Japan
6.18 Ono Pharmaceutical
6.19 Zeria Pharmaceutical
6.20 Kissei Pharmaceutical
6.21 Kang Stem Biotech
6.22 Kaken Pharmaceutical
6.23 Hutchison Medi Pharma
6.24 Amgen

7 Gastrointestinal Therapeutics Manufacturing Cost Analysis
7.1 Gastrointestinal Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Gastrointestinal Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Therapeutics Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Gastrointestinal Therapeutics Market Forecast (2017-2022)
11.1 United States Gastrointestinal Therapeutics Sales, Revenue Forecast (2017-2022)
11.2 United States Gastrointestinal Therapeutics Sales Forecast by Type (2017-2022)
11.3 United States Gastrointestinal Therapeutics Sales Forecast by Application (2017-2022)
11.4 Gastrointestinal Therapeutics Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Gastrointestinal Therapeutics
Table Classification of Gastrointestinal Therapeutics
Figure United States Sales Market Share of Gastrointestinal Therapeutics by Type in 2015
Table Application of Gastrointestinal Therapeutics
Figure United States Sales Market Share of Gastrointestinal Therapeutics by Application in 2015
Figure IBD Examples
Figure Irritable Bowel Syndrome (IBS) Examples
Figure United States Gastrointestinal Therapeutics Sales and Growth Rate (2012-2022)
Figure United States Gastrointestinal Therapeutics Revenue and Growth Rate (2012-2022)
Table United States Gastrointestinal Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Gastrointestinal Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gastrointestinal Therapeutics Sales Share by Manufacturers
Figure 2016 Gastrointestinal Therapeutics Sales Share by Manufacturers
Table United States Gastrointestinal Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Gastrointestinal Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gastrointestinal Therapeutics Revenue Share by Manufacturers
Table 2016 United States Gastrointestinal Therapeutics Revenue Share by Manufacturers
Table United States Market Gastrointestinal Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gastrointestinal Therapeutics Average Price of Key Manufacturers in 2015
Figure Gastrointestinal Therapeutics Market Share of Top 3 Manufacturers
Figure Gastrointestinal Therapeutics Market Share of Top 5 Manufacturers
Table United States Gastrointestinal Therapeutics Sales by States (2012-2017)
Table United States Gastrointestinal Therapeutics Sales Share by States (2012-2017)
Figure United States Gastrointestinal Therapeutics Sales Market Share by States in 2015
Table United States Gastrointestinal Therapeutics Revenue and Market Share by States (2012-2017)
Table United States Gastrointestinal Therapeutics Revenue Share by States (2012-2017)
Figure Revenue Market Share of Gastrointestinal Therapeutics by States (2012-2017)
Table United States Gastrointestinal Therapeutics Price by States (2012-2017)
Table United States Gastrointestinal Therapeutics Sales by Type (2012-2017)
Table United States Gastrointestinal Therapeutics Sales Share by Type (2012-2017)
Figure United States Gastrointestinal Therapeutics Sales Market Share by Type in 2015
Table United States Gastrointestinal Therapeutics Revenue and Market Share by Type (2012-2017)
Table United States Gastrointestinal Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Therapeutics by Type (2012-2017)
Table United States Gastrointestinal Therapeutics Price by Type (2012-2017)
Figure United States Gastrointestinal Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Gastrointestinal Therapeutics Sales by Application (2012-2017)
Table United States Gastrointestinal Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Therapeutics Sales Market Share by Application in 2015
Table United States Gastrointestinal Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Gastrointestinal Therapeutics Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Gastrointestinal Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Gastrointestinal Therapeutics Sales Market Share (2012-2017)
Table Procter & Gamble Basic Information List
Table Tillotts Pharma Basic Information List
Table Shire Pharmaceuticals Basic Information List
Table GlaxoSmithKline Basic Information List
Table RedHill Biopharma Basic Information List
Table Salix Pharmaceuticals Basic Information List
Table TSD Japan Basic Information List
Table Ono Pharmaceutical Basic Information List
Table Zeria Pharmaceutical Basic Information List
Table Kissei Pharmaceutical Basic Information List
Table Kang Stem Biotech Basic Information List
Table Kaken Pharmaceutical Basic Information List
Table Hutchison Medi Pharma Basic Information List
Table Amgen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Therapeutics
Figure Manufacturing Process Analysis of Gastrointestinal Therapeutics
Figure Gastrointestinal Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Therapeutics Major Manufacturers in 2015
Table Major Buyers of Gastrointestinal Therapeutics
Table Distributors/Traders List
Figure United States Gastrointestinal Therapeutics Production and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Table United States Gastrointestinal Therapeutics Production Forecast by Type (2017-2022)
Table United States Gastrointestinal Therapeutics Consumption Forecast by Application (2017-2022)
Table United States Gastrointestinal Therapeutics Sales Forecast by States (2017-2022)
Table United States Gastrointestinal Therapeutics Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *